A citation-based method for searching scientific literature

Daniel S Reich, Claudia F Lucchinetti, Peter A Calabresi. N Engl J Med 2018
Times Cited: 907







List of co-cited articles
589 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria.
Alan J Thompson, Brenda L Banwell, Frederik Barkhof, William M Carroll, Timothy Coetzee, Giancarlo Comi, Jorge Correale, Franz Fazekas, Massimo Filippi, Mark S Freedman,[...]. Lancet Neurol 2018
25

Multiple sclerosis.
Alan J Thompson, Sergio E Baranzini, Jeroen Geurts, Bernhard Hemmer, Olga Ciccarelli. Lancet 2018
745
16


Defining the clinical course of multiple sclerosis: the 2013 revisions.
Fred D Lublin, Stephen C Reingold, Jeffrey A Cohen, Gary R Cutter, Per Soelberg Sørensen, Alan J Thompson, Jerry S Wolinsky, Laura J Balcer, Brenda Banwell, Frederik Barkhof,[...]. Neurology 2014
12

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Chris H Polman, Stephen C Reingold, Brenda Banwell, Michel Clanet, Jeffrey A Cohen, Massimo Filippi, Kazuo Fujihara, Eva Havrdova, Michael Hutchinson, Ludwig Kappos,[...]. Ann Neurol 2011
11


Immunopathology of multiple sclerosis.
Calliope A Dendrou, Lars Fugger, Manuel A Friese. Nat Rev Immunol 2015
10

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.
Xavier Montalban, Stephen L Hauser, Ludwig Kappos, Douglas L Arnold, Amit Bar-Or, Giancarlo Comi, Jérôme de Seze, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer,[...]. N Engl J Med 2017
842
8

Rising prevalence of multiple sclerosis worldwide: Insights from the Atlas of MS, third edition.
Clare Walton, Rachel King, Lindsay Rechtman, Wendy Kaye, Emmanuelle Leray, Ruth Ann Marrie, Neil Robertson, Nicholas La Rocca, Bernard Uitdehaag, Ingrid van der Mei,[...]. Mult Scler 2020
217
8


Pathological mechanisms in progressive multiple sclerosis.
Don H Mahad, Bruce D Trapp, Hans Lassmann. Lancet Neurol 2015
630
7

Treatment of Multiple Sclerosis: A Review.
Stephen L Hauser, Bruce A C Cree. Am J Med 2020
105
7

Multiple sclerosis - a review.
R Dobson, G Giovannoni. Eur J Neurol 2019
406
7

M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.
Veronique E Miron, Amanda Boyd, Jing-Wei Zhao, Tracy J Yuen, Julia M Ruckh, Jennifer L Shadrach, Peter van Wijngaarden, Amy J Wagers, Anna Williams, Robin J M Franklin,[...]. Nat Neurosci 2013
995
6

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study.
Ludwig Kappos, Amit Bar-Or, Bruce A C Cree, Robert J Fox, Gavin Giovannoni, Ralf Gold, Patrick Vermersch, Douglas L Arnold, Sophie Arnould, Tatiana Scherz,[...]. Lancet 2018
406
6

B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Stephen L Hauser, Emmanuelle Waubant, Douglas L Arnold, Timothy Vollmer, Jack Antel, Robert J Fox, Amit Bar-Or, Michael Panzara, Neena Sarkar, Sunil Agarwal,[...]. N Engl J Med 2008
6

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.
Simon Faissner, Jason R Plemel, Ralf Gold, V Wee Yong. Nat Rev Drug Discov 2019
151
6

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.
Alexander Rae-Grant, Gregory S Day, Ruth Ann Marrie, Alejandro Rabinstein, Bruce A C Cree, Gary S Gronseth, Michael Haboubi, June Halper, Jonathan P Hosey, David E Jones,[...]. Neurology 2018
247
6

Placebo-controlled phase 3 study of oral BG-12 or glatiramer in multiple sclerosis.
Robert J Fox, David H Miller, J Theodore Phillips, Michael Hutchinson, Eva Havrdova, Mariko Kita, Minhua Yang, Kartik Raghupathi, Mark Novas, Marianne T Sweetser,[...]. N Engl J Med 2012
907
6

Cortical demyelination and diffuse white matter injury in multiple sclerosis.
Alexandra Kutzelnigg, Claudia F Lucchinetti, Christine Stadelmann, Wolfgang Brück, Helmut Rauschka, Markus Bergmann, Manfred Schmidbauer, Joseph E Parisi, Hans Lassmann. Brain 2005
5

Multiple sclerosis.
Massimo Filippi, Amit Bar-Or, Fredrik Piehl, Paolo Preziosa, Alessandra Solari, Sandra Vukusic, Maria A Rocca. Nat Rev Dis Primers 2018
401
5

Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity.
Paul Browne, Dhia Chandraratna, Ceri Angood, Helen Tremlett, Chris Baker, Bruce V Taylor, Alan J Thompson. Neurology 2014
606
5

Recommendations for cognitive screening and management in multiple sclerosis care.
Rosalind Kalb, Meghan Beier, Ralph Hb Benedict, Leigh Charvet, Kathleen Costello, Anthony Feinstein, Jeffrey Gingold, Yael Goverover, June Halper, Colleen Harris,[...]. Mult Scler 2018
127
5

The relation between inflammation and neurodegeneration in multiple sclerosis brains.
Josa M Frischer, Stephan Bramow, Assunta Dal-Bianco, Claudia F Lucchinetti, Helmut Rauschka, Manfred Schmidbauer, Henning Laursen, Per Soelberg Sorensen, Hans Lassmann. Brain 2009
889
5

Multiple sclerosis.
Alastair Compston, Alasdair Coles. Lancet 2008
5

Role of the innate and adaptive immune responses in the course of multiple sclerosis.
Bernhard Hemmer, Martin Kerschensteiner, Thomas Korn. Lancet Neurol 2015
306
5

Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway.
Ralf A Linker, De-Hyung Lee, Sarah Ryan, Anne M van Dam, Rebecca Conrad, Pradeep Bista, Weike Zeng, Xiaoping Hronowsky, Alex Buko, Sowmya Chollate,[...]. Brain 2011
722
5

Association of Chronic Active Multiple Sclerosis Lesions With Disability In Vivo.
Martina Absinta, Pascal Sati, Federica Masuzzo, Govind Nair, Varun Sethi, Hadar Kolb, Joan Ohayon, Tianxia Wu, Irene C M Cortese, Daniel S Reich. JAMA Neurol 2019
144
5

Slow expansion of multiple sclerosis iron rim lesions: pathology and 7 T magnetic resonance imaging.
Assunta Dal-Bianco, Günther Grabner, Claudia Kronnerwetter, Michael Weber, Romana Höftberger, Thomas Berger, Eduard Auff, Fritz Leutmezer, Siegfried Trattnig, Hans Lassmann,[...]. Acta Neuropathol 2017
175
5

Long-term evolution of multiple sclerosis disability in the treatment era.
Bruce A C Cree, Pierre-Antoine Gourraud, Jorge R Oksenberg, Carolyn Bevan, Elizabeth Crabtree-Hartman, Jeffrey M Gelfand, Douglas S Goodin, Jennifer Graves, Ari J Green, Ellen Mowry,[...]. Ann Neurol 2016
222
5

Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis.
Owain W Howell, Cheryl A Reeves, Richard Nicholas, Daniele Carassiti, Bishan Radotra, Steve M Gentleman, Barbara Serafini, Francesca Aloisi, Federico Roncaroli, Roberta Magliozzi,[...]. Brain 2011
490
5

TREM2 activation on microglia promotes myelin debris clearance and remyelination in a model of multiple sclerosis.
Francesca Cignarella, Fabia Filipello, Bryan Bollman, Claudia Cantoni, Alberto Locca, Robert Mikesell, Melissa Manis, Adiljan Ibrahim, Li Deng, Bruno A Benitez,[...]. Acta Neuropathol 2020
69
7

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis.
Stephen L Hauser, Amit Bar-Or, Giancarlo Comi, Gavin Giovannoni, Hans-Peter Hartung, Bernhard Hemmer, Fred Lublin, Xavier Montalban, Kottil W Rammohan, Krzysztof Selmaj,[...]. N Engl J Med 2017
812
5

Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis.
Ralf Gold, Ludwig Kappos, Douglas L Arnold, Amit Bar-Or, Gavin Giovannoni, Krzysztof Selmaj, Carlo Tornatore, Marianne T Sweetser, Minhua Yang, Sarah I Sheikh,[...]. N Engl J Med 2012
5

Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
Josa M Frischer, Stephen D Weigand, Yong Guo, Nilufer Kale, Joseph E Parisi, Istvan Pirko, Jay Mandrekar, Stephan Bramow, Imke Metz, Wolfgang Brück,[...]. Ann Neurol 2015
323
5


Multiple Sclerosis: Mechanisms and Immunotherapy.
Clare Baecher-Allan, Belinda J Kaskow, Howard L Weiner. Neuron 2018
359
5

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis.
J William L Brown, Alasdair Coles, Dana Horakova, Eva Havrdova, Guillermo Izquierdo, Alexandre Prat, Marc Girard, Pierre Duquette, Maria Trojano, Alessandra Lugaresi,[...]. JAMA 2019
189
5

The prevalence of MS in the United States: A population-based estimate using health claims data.
Mitchell T Wallin, William J Culpepper, Jonathan D Campbell, Lorene M Nelson, Annette Langer-Gould, Ruth Ann Marrie, Gary R Cutter, Wendy E Kaye, Laurie Wagner, Helen Tremlett,[...]. Neurology 2019
422
5

Vitamin D as an early predictor of multiple sclerosis activity and progression.
Alberto Ascherio, Kassandra L Munger, Rick White, Karl Köchert, Kelly Claire Simon, Chris H Polman, Mark S Freedman, Hans-Peter Hartung, David H Miller, Xavier Montalbán,[...]. JAMA Neurol 2014
277
4

Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS).
Cris S Constantinescu, Nasr Farooqi, Kate O'Brien, Bruno Gran. Br J Pharmacol 2011
736
4

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination.
C Lucchinetti, W Brück, J Parisi, B Scheithauer, M Rodriguez, H Lassmann. Ann Neurol 2000
4

Lesion genesis in a subset of patients with multiple sclerosis: a role for innate immunity?
Christina Marik, Paul A Felts, Jan Bauer, Hans Lassmann, Kenneth J Smith. Brain 2007
231
4


Effect of high-dose simvastatin on brain atrophy and disability in secondary progressive multiple sclerosis (MS-STAT): a randomised, placebo-controlled, phase 2 trial.
Jeremy Chataway, Nadine Schuerer, Ali Alsanousi, Dennis Chan, David MacManus, Kelvin Hunter, Val Anderson, Charles R M Bangham, Shona Clegg, Casper Nielsen,[...]. Lancet 2014
262
4

Deep gray matter volume loss drives disability worsening in multiple sclerosis.
Arman Eshaghi, Ferran Prados, Wallace J Brownlee, Daniel R Altmann, Carmen Tur, M Jorge Cardoso, Floriana De Angelis, Steven H van de Pavert, Niamh Cawley, Nicola De Stefano,[...]. Ann Neurol 2018
189
4

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
Raju Kapoor, Pei-Ran Ho, Nolan Campbell, Ih Chang, Aaron Deykin, Fiona Forrestal, Nisha Lucas, Bei Yu, Douglas L Arnold, Mark S Freedman,[...]. Lancet Neurol 2018
155
4

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial.
Jeremy Chataway, Floriana De Angelis, Peter Connick, Richard A Parker, Domenico Plantone, Anisha Doshi, Nevin John, Jonathan Stutters, David MacManus, Ferran Prados Carrasco,[...]. Lancet Neurol 2020
54
7

Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
Giulio Disanto, Christian Barro, Pascal Benkert, Yvonne Naegelin, Sabine Schädelin, Antonella Giardiello, Chiara Zecca, Kaj Blennow, Henrik Zetterberg, David Leppert,[...]. Ann Neurol 2017
520
4

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial.
Hans-Peter Hartung, Richard Gonsette, Nikolaus König, Hubert Kwiecinski, Andreas Guseo, Sean P Morrissey, Hilmar Krapf, Thomas Zwingers. Lancet 2002
638
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.